A single element in the phosphoenolpyruvate carboxykinase gene mediates thiazolidinedione action specifically in adipocytes

Biochimie

Volumn 83, Issue 10, 2001, Pages 933-943

  Glorian, Martine ^a   Duplus, Eric ^a   Beale, Elmus G ^b   Scott, Donald K ^c   Granner, Daryl K ^c   Forest, Claude ^a  

^a INSERM   (France)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adipose tissue; Glyceroneogenesis; Hepatoma; Peroxisome proliferator activated receptors; Type 2 diabetes

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; CHIMERIC PROTEIN; CHLORAMPHENICOL ACETYLTRANSFERASE; ENZYME; FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RETINOID X RECEPTOR; ROSIGLITAZONE;

ADIPOCYTE; ADIPOSE TISSUE; ALCOHOL METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL SPECIFICITY; CONTROLLED STUDY; DNA RESPONSIVE ELEMENT; DNA TRANSFECTION; DRUG EFFECT; DRUG MECHANISM; DRUG RESPONSE; ENZYME ASSAY; ENZYME REGULATION; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; GENE ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSCRIPTION; MALE; MUTAGENESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; RAT; TISSUE SPECIFICITY;

EID: 0035214264     PISSN: 03009084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0300-9084(01)01343-8     Document Type: Article

References (67)

1. What if Minkowski had been ageusic? An alternative angle on diabetes
2. High fat diet-induced insulin resistance. Lessons and implications from animal studies
3. Measurement of plasma glucose, free fatty acid, lactate, and insulin for 24 h in patients with NIDDM
4. Role of free fatty acids in the insulin resistance of non-insulin-dependent diabetes
5. Regulatory interactions between lipids and carbohydrates: The glucose fatty acid cycle after 35 years
6. A fatty acid-dependent step is critically important for both glucose- and non-glucose-stimulated insulin secretion
7. Fatty acid-induced beta cell apoptosis: A link between obesity and diabetes
8. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance
9. BRL 49653 blocks the lipolytic actions of tumor necrosis factor-alpha: A potential new insulin-sensitizing mechanism for thiazolidinediones
10. A possible physiological role for glyceroneogenesis in rat adipose tissue
11. Increased adipose tissue glyceroneogenesis in rats adapted to a high protein, carbohydrate-free diet
12. Glyceroneogenesis and the source of glycerol for hepatic triacylglycerol synthesis in humans
13. Thiazolidinediones in the treatment of insulin resistance and type II diabetes
14. Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones
15. The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat
16. Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma
17. TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone
18. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)
19. DNA binding properties of peroxisome proliferator-activated receptor subtypes on various natural peroxisome proliferator response elements. Importance of the 5′-flanking region
20. Transcriptional regulation of adipogenesis
21. Troglitazone, an antidiabetic agent, inhibits cholesterol biosynthesis through a mechanism independent of peroxisome proliferator-activated receptor-gamma
22. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation
23. Adipose expression of the phosphoenolpyruvate carboxykinase promoter requires peroxisome proliferator-activated receptor gamma and 9-cis-retinoic acid receptor binding to an adipocyte-specific enhancer in vivo
24. Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat
25. Glucocorticoids repress induction by thiazolidinediones, fibrates, and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes
26. Widespread long-term gene transfer to mouse skeletal muscles and heart
27. Adenovirus enhancement of polyethylenimine-mediated transfer of regulated genes in differentiated cells
28. Fatty acids and fibrates are potent inducers of transcription of the phosphenolpyruvate carboxykinase gene in adipocytes
29. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
30. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
31. Rat hepatic cytosolic phosphoenolpyruvate carboxykinase (GTP). Structures of the protein, messenger RNA, and gene
32. Hormone-sensitive lipase: Sequence, expression, and chromosomal localization to 19 cent-q13.3
33. Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation- dependent proteins during adipocyte development
34. The sequence of cDNA encoding lipoprotein lipase. A member of a lipase gene family
35. Cloning of DNA complementary to rat liver fatty acid synthetase mRNA
36. Cloning, sequencing, and expression of a cDNA encoding rat liver carnitine palmitoyltransferase I. Direct evidence that a single polypeptide is involved in inhibitor interaction and catalytic function
37. Identification of an adipocyte-specific negative glucose response region in the cytosolic aspartate aminotransferase gene
38. Multihormonal regulation of phosphoenolpyruvate carboxykinase- chloramphenicol acetyltransferase fusion genes. Insulin's effects oppose those of cAMP and dexamethasone
39. Glucocorticoids use a positive liver element to repress fibrate-induced adipose transcription of the phosphoenolpyruvate carboxykinase gene
40. Expression of the phosphoenolpyruvate carboxykinase gene in 3T3-F442A adipose cells: Effects of retinoic acid and differentiation
41. A simple phase-extraction assay for chloramphenicol acyltransferase activity
42. A high-efficiency HeLa cell nuclear transcription extract
43. mPPAR gamma 2: Tissue-specific regulator of an adipocyte enhancer
44. Peroxisome proliferator and retinoid signaling pathways co-regulate preadipocyte phenotype and survival
45. Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors
46. Peroxisome proliferator-activated receptor agonists
47. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
48. Regulation of phosphoenolpyruvate carboxykinase (GTP) gene expression
49. Detection of peroxisome proliferators using a reporter construct derived from the rat acyl-CoA oxidase promoter in the rat liver cell line H-4-II-E
50. Troglitazone inhibits expression of the phosphoenolpyruvate carboxykinase gene by an insulin-independent mechanism
51. Cyclic AMP and fatty acids increase carnitine palmitoyltransferase I gene transcription in cultured fetal rat hepatocytes
52. Long-chain fatty acids regulate liver carnitine palmitoyltransferase I gene (L-CPT I) expression through a peroxisome-proliferator-activated receptor alpha (PPARalpha)-independent pathway
53. Peroxisome proliferator activated receptor γ (PPARγ) and chicken ovelbumin upstream promoter transcription factor II (COUP-TFII) negatively regulate the phosphoenolpyruvate carboxykinase promoter via a common element
54. PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene
55. PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene
56. Thiazolidinediones inhibit lipoprotein lipase activity in adipocytes
57. Thiazolidinediones and insulin resistance: Peroxisome proliferator-activated receptor gamma activation stimulates expression of the CAP gene
58. Regulation of gene expression by activation of the peroxisome proliferator-activated receptor gamma with rosiglitazone (BRL 49653) in human adipocytes
59. Increase in uncoupling protein-2 mRNA expression by BRL49653 and bromopalmitate in human adipocytes
60. Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor gamma activation has coordinate effects on gene expression in multiple insulin-sensitive tissues
61. Regulation of the cytosolic aspartate aminotransferase housekeeping gene promoter by glucocorticoids, cAMP, and insulin
62. Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting
63. Nuclear hormone receptor coregulators in action: Diversity for shared tasks
64. Subtype-and response element-dependent differences in transactivation by peroxisome proliferator-activated receptors alpha and gamma
65. A retinoic acid response element is part of a pleiotropic domain in the phosphoenolpyruvate carboxykinase gene
66. The orphan receptors COUP-TF and HNF-4 serve as accessory factors required for induction of phosphoenolpyruvate carboxykinase gene transcription by glucocorticoids